Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, fatigue is a recognised side effect of GLP-1 and dual GIP/GLP-1 weight loss injections. Most people who experience it notice tiredness in the first few weeks, typically after starting or after a dose increase, and it usually settles as the body adjusts. It is not a reason to stop without speaking to your prescriber first. These are prescription-only medicines — a clinician reviews whether they are right for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scenario: you have been on treatment for five or six days, you are eating less than before, and by early afternoon you hit a wall. You are not ill exactly, just flat. A question our prescribers hear regularly is whether the injection itself is responsible, or whether something else is going on.
The honest answer is: usually both. GLP-1 and dual GIP/GLP-1 receptor agonists slow gastric emptying and reduce appetite quite sharply at first. Your body is taking in fewer calories than it was, sometimes substantially fewer, and that energy gap can show up as tiredness before your metabolism catches up. On top of that, the nausea that some people experience (particularly in the early weeks) disrupts sleep quality even when people do not realise it. Poor sleep compounds the fatigue cycle.
The NHS medicines page for tirzepatide lists fatigue among the recognised side effects, alongside the more widely discussed gastrointestinal symptoms. It appears in the semaglutide data too. Neither medicine is unusual in this respect, it is a pattern seen across this class of treatments. For more on how other physical symptoms present during the early weeks, the guide to nausea and sickness on weight loss injections covers the overlap in useful detail.
One practical check you can do right now: take thirty seconds to think through what you actually ate and drank yesterday. People on these medicines often underestimate how little fluid they consumed, because appetite suppression dampens thirst cues alongside hunger. Mild dehydration alone can account for a significant drop in energy.
Not necessarily. The distinction worth making is between tiredness that is mild, tied to the early adjustment period, and improving week by week, versus fatigue that is worsening, or that comes with other symptoms like a rapid heartbeat, feeling faint on standing, or very dark urine. The first pattern is common and usually self-limiting. The second pattern deserves a call to your prescriber or, if symptoms are acute, to your GP or 111.
Dehydration is the most frequently overlooked driver of persistent fatigue in people on these medicines. GI side effects (nausea, vomiting, loose stools) cause fluid losses that are easy to underestimate. Replacing fluids consistently, and prioritising foods with a higher water content when appetite is low, makes a measurable difference for many people. Protein adequacy matters too: eating too little protein while in a calorie deficit accelerates the kind of tiredness that feels muscular and heavy rather than sleepy. If you are wondering whether muscle loss might be part of what you are feeling, the page on muscle and weight loss injections covers what the evidence currently says.
The MHRA's published safety communications for GLP-1 medicines include guidance on when fatigue should prompt medical attention, particularly if it accompanies severe abdominal pain, a symptom that warrants urgent review. Always keep the Patient Information Leaflet that comes with your pen to hand; the clinical detail on side effects there is specific to your medicine and dose.
The most useful frame here is that early fatigue is temporary for most people, and there are practical things that move it along faster. Consistent sleep timing helps more than most people expect, going to bed and waking at the same time anchors circadian rhythm even when you are eating less. Strength-based movement, even light resistance exercise, signals to your body that lean tissue is needed, which tends to improve energy over a couple of weeks rather than deplete it further.
Injecting on the same day each week at a consistent time is also worth doing properly: rotate the site each time between abdomen, thigh and upper arm, and clean the skin first. If you are on tirzepatide and want a practical overview of the injection process, the weight loss injection guide has the relevant detail, and alcohol swabs are available if you need them.
For a broader picture of how weight loss injections work and what to expect across the first few months, the information on weight loss injections page covers the full arc. And if tiredness is not the only new thing you have noticed, some people also ask whether treatment is changing how they look, and the page on whether weight loss injections make you look older addresses that question alongside the page on hair changes.
Fatigue that is not improving after two to three weeks on a stable dose, fatigue that is worsening, or any tiredness that arrives alongside chest tightness, severe stomach pain, confusion, or signs of dehydration should all prompt a conversation with a clinician rather than a wait-and-see approach. These are not reasons to panic, they are reasons to ask.
At nume
At nume, a GPhC-registered Independent Prescriber reviews every patient's treatment, not a triage algorithm. Side effects are exactly the kind of thing the aftercare team is there for, seven days a week. You can see how the clinical team approaches this on the clinical team page. If you have questions before starting, the FAQs cover the most common ones, and you can always get in touch directly.
If you are at the stage of thinking about whether treatment is right for you, starting a free consultation is the next step, it is reviewed the same day by a real prescriber, with no obligation to proceed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.